Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy

por Goldschmidt, Jerome, Hart, Lowell, Scott, Jeffrey, Boykin, Kristen, Bailey, Ray, Heritage, Trevor, Lopez-Gonzalez, Lorena, Zhou, Zheng-Yi, Edwards, Marie Louise, Monnette, Alisha, Ogbonnaya, Augustina, Deyoung, Kathryn, Venkatasetty, Divea, Shi, Ping, Aton, Lindsay, Huang, Huan, Conkling, Paul R., Gordan, Lucio
Publicado 2023

Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung...

por Li, Chao, Hart, Lowell, Owonikoko, Taofeek K., Aljumaily, Raid, Rocha Lima, Caio Max, Conkling, Paul R., Webb, Roy Timothy, Jotte, Robert M., Schuster, Steven, Edenfield, William J., Smith, Deborah A., Sale, Mark, Roberts, Patrick J., Malik, Rajesh K., Sorrentino, Jessica A.
Publicado 2021